Partner
Copenhagen

Jeppe Brinck-Jensen

Photo of Jeppe Brinck-Jensen

Jeppe Brinck-Jensen is a specialist in the area of intellectual property law

Jeppe Brinck-Jensen works with intellectual property law. He renders advice on primarily disputes and agreements in the areas of patents, trademarks and trade secrets to research enterprises in the life sciences, medical, cleantech and food industries in particular.

He is one of Denmark's most experienced litigators in intellectual property proceedings.

Chambers places Jeppe Brinck-Jensen in Band 1 in intellectual property law.

Recent major legal proceedings:

  • Illumina vs. BGI – patent for gen sequencing device
  • Teva vs. Mylan (copemyl) – Patent for Copaxone®
  • Chr. Hansen vs. DuPont (bifidobacterium) - Trademark right in BB12®
  • Demant vs. Retune – Patent for noise-reducing algorithm - trade secrets
  • Valmet Automation vs. Emco – trade secrets
  • Astra Zeneca vs. Krka (esomeprazol) – Patent for Nexium®
  • Gilead vs. Accord et al. - (tenofivir dispoproxil + emtricitabine) – SPC for Truvada® and Atripla®
  • Novartis vs. Orifarm Generics - (rivastigmine) – Patent for Exelon®
  • Mirrx Therapeutics vs. Santaris Pharma A/S – Right in invention regarding RNA
  • Merck vs. Orifarm - (montelukast) - parallel import – Trademark for Nuvaring®
  • Merck vs. Orifarm - specific mechanism – SPC for Singulair®

(A number of the above cases were conducted by Jeppe before he joined Bech-Bruun)

The Team

Intellectual Property

  • Intellectual Property
  • Dispute Resolution
  • Life Science
00 / 00

Ratings

Jeppe Brinck-Jensen rises in the rankings this year following impressive feedback and recognition for his work. He is proficient in a broad range of contentious IP mandates, ranging from patent, SPC and utility model disputes to trade mark and trade secret cases. Clients enthuse that "he has a high degree of commercial understanding and the ability to adapt to the client’s needs." (2022)

Jeppe Brinck-Jensen is ranked as a leading individual as regards Intellectual Property by Chambers Global and Chambers Europe. Jeppe Brinck-Jensen is proficient in a broad range of contentious IP mandates, from patent, SPC and utility model disputes to trade mark and trade secret cases. Clients enthuse that he is "pleasant to work with, thorough and very experienced in national and international IP disputes." (2021)

Jeppe Brinck-Jensen is ranked as a leading individual as regards Intellectual Property by Chambers Global and Chambers Europe. Jeppe Brinck-Jensen acts for clients on patent disputes, especially within the life sciences sector. He also advises on trade secrets matters. One client praises his approach to cases, stating he is "very intelligent and commercially skilled" and adding that he "has a pragmatic way of handling matters." Another client notes he is "efficient and calm, and produces good material." (2020) 

Jeppe Brinck-Jensen is ranked as a leading individual as regards Intellectual Property by Chambers Global and Chambers Europe. Jeppe Brinck-Jensen is described by clients as "very skilled" and good at giving "pragmatic answers." Jeppe Brinck-Jensen gains recognition for his portfolio in patent cases, especially in the pharmaceutical industry. (2019) 

Jeppe Brinck-Jensen has been ranked in Band 1 as top lawyer within Intellectual Property by Chambers and Partners Global.

Chambers and Partners Global, Intellectual Property

Iam1000 logo

"Jeppe has an exceptional legal mind and a strong presence in court, and can present complex issues through simplified examples and visual aids which are easily understood by judges and laypeople. He is also always available" (2021)

Jeppe Brinck-Jensen, a Supreme Court-admitted advocate who turns even the most complex technical brief into a walk in the park. Adept at negotiating labyrinthine licensing agreements (2020)

Jeppe Brinck-Jensen is both effective in the courtroom and the boardroom. Brinck-Jensen's pharmaceutical licensing prowess leads one client to deem him a "competent, skilled, accessible and straight-to-the-point attorney". (2019)

Jeppe Brinck-Jensen is recommended in Denmark for patent litigation and transactions. "A star performer in court, Jeppe Brinck Jensen has really strengthened the offering. A rare combination of theoretical intelligence and business acumen, he is an extremely skilled life sciences litigator who offers outstanding advice on patent infringement and supplementary protection certificates. Approachable, efficient and concise, he is a pleasure to work with." (2018)

IAM Patent

WTR-Logo

When it comes to pharmaceutical patent disputes, Jeppe Brinck-Jensen is the man of the hour, although his impeccable advocacy also translates well to the trademark side. He has lately been representing Lundbeck, Novo Nordisk and LEO Pharma in a case concerning the implications of the Falsified Medicines Directive on parallel imports, which has been referred to the CJEU (2022)

Jeppe Brinck-Jensen is recommended in Denmark for enforcement and litigation of trademarks. Brinck-Jensen is best known for his pharmaceutical patent work, but is hailed as a "splendid litigator and adviser" in the trademark field too. (2021)

Jeppe Brinck-Jensen is recommended in Denmark for enforcement and litigation of trademarks: "First-class litigator Jeppe Brinck-Jensen lead the charge in the pharmaceutical and life sciences spaces. Brinck-Jensen splits his time between pleading at the Supreme Court and drafting lucrative licensing agreements." (2020)

World Trademark Review

 

Publications

  • Employees' Intellectual Property Rights, Wolters Kluwer, 2015. Book
  • Ansattes immaterielle rettigheder, Jurist og Økonomforbundets forlag, 2013. Book
  • Immaterialretlige aftaleforhold, author of chapter 6 ”Licensindrømmelse og overdragelse” and chapter 21 ”Patenter i sameje”, Dansk immaterialret III, Gads Forlag, 2013. Book
  • The Specific Mechanism Apples to pediatricly extended SPCs for all strengths of the pharmaceutical , ILO Healthcare & Life Sciences, 2016. Article
  • No particular importance attached to European invalidity judgments regarding European patent, ILO Healthcare & Life Sciences, 2016. Article
  • Patent attorney's invention found not to be unlawful use of confidential information, ILO Healthcare & Life Sciences, 2015. Article
  • Beskyttelse af erhvervshemmeligheder, Dansk Biotek, 2015. Article
  • Dispensing generic drug infringes second medical use patent, ILO Healthcare & Life Sciences, 2015. Article
  • Repackaging into neutral packages must include a trademark statement, ILO Healthcare & Life Sciences, 2015. Article
  • Patenter i sameje i dansk ret, NIR, 2013. Article
  • Fokus på immaterialrettigheder i due diligence-processen, Dansk Biotek, 2012. Article
  • Dansk administrativ praksis om opretholdelse af varemærker stemmer næppe med retspraksis, NIR, 2007. Article

Education and language

  • Admission to practice law
  • LLM in Intellectual Property
  • Master of Laws
  • Danish
  • English